NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,359,460 | -9.1% | 595,694 | 0.0% | 5.81% | +7.2% |
| Q2 2023 | $28,986,470 | -33.5% | 595,694 | -24.1% | 5.42% | -36.1% |
| Q1 2023 | $43,577,315 | +33.1% | 784,894 | -3.7% | 8.48% | +12.3% |
| Q4 2022 | $32,738,309 | +25.4% | 814,994 | +36.7% | 7.55% | +26.0% |
| Q3 2022 | $26,116,000 | +29.1% | 595,994 | +4.4% | 5.99% | +27.0% |
| Q2 2022 | $20,236,000 | +11.2% | 570,994 | +27.6% | 4.72% | +5.2% |
| Q1 2022 | $18,204,000 | -7.9% | 447,494 | +111.4% | 4.48% | -6.9% |
| Q4 2021 | $19,770,000 | +7.9% | 211,694 | +28.7% | 4.82% | -17.1% |
| Q3 2021 | $18,331,000 | -1.1% | 164,494 | +0.8% | 5.81% | -8.5% |
| Q2 2021 | $18,527,000 | +8.4% | 163,194 | -3.1% | 6.36% | -5.3% |
| Q1 2021 | $17,099,000 | +118.6% | 168,394 | +114.2% | 6.71% | +34.2% |
| Q4 2020 | $7,822,000 | – | 78,600 | – | 5.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |